✦ LIBER ✦

Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study

✍ Scribed by Janice M. Rusnak; Paul Gibbs; Ellen Boudreau; Denise P. Clizbe; Phillip Pittman

Book ID: 116963558
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 396 KB
Volume: 29
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2011.02.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity of an inactivated Rift Va

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience

✍ Phillip R. Pittman; C.T. Liu; Timothy L. Cannon; Richard S. Makuch; Joseph A. Ma 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Evaluation of a new Rift Valley fever va

Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials

✍ Gilcin F. Meadors III; Paul H. Gibbs; C.J. Peters 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 588 KB

Safety and immunogenicity of recombinant

Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep

✍ John C. Morrill; Richard C. Laughlin; Nandadeva Lokugamage; Roberta Pugh; Elena 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 454 KB

Immunogenicity and efficacy of a chimpan

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice

✍ Warimwe, George M; Lorenzo, Gema; Lopez-Gil, Elena; Reyes-Sandoval, Arturo; Cott 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 599 KB

Immunogenicity and safety of a new inact

Immunogenicity and safety of a new inactivated hepatitis a vaccine in a comparative study

✍ Dr. Christian Goilav; Jane Zuckerman; Michael Lafrenz; Emmanuel Vidor; Sabine La 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

## Abstract A multicentre, controlled, randomised, open, comparative trial including 839 healthy adult volunteers was carried out in order to compare the immunogenicity and reactogenicity of two vaccines against hepatitis A virus (HAV) during primary immunization and after booster injection. The fi

Safety, immunogenicity and antibody pers

Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children

✍ Olga Castillo de Febres; Maria Chacon de Petrola; Laddy Casanova de Escalona; Os 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 152 KB